{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:29:18Z","timestamp":1790666958681,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbmt.2018.05.006","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T04:59:46Z","timestamp":1525928386000},"page":"1873-1880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Platelet Transfusion Refractoriness in Single-Unit Cord Blood Transplantation for Adults: Risk Factors and Clinical Outcomes"],"prefix":"10.1016","volume":"24","author":[{"given":"Susumu","family":"Tanoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1953-8463","authenticated-orcid":false,"given":"Takaaki","family":"Konuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Oiwa-Monna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Jimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arinobu","family":"Tojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbmt.2018.05.006_bib0010","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1200\/JCO.2017.76.1734","article-title":"Platelet transfusion for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"36","author":"Schiffer","year":"2018","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.bbmt.2018.05.006_bib0015","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1111\/trf.13738","article-title":"Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials","volume":"56","author":"Christou","year":"2016","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.bbmt.2018.05.006_bib0020","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1537-2995.1995.35895357895.x","article-title":"Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients","volume":"35","author":"Hogge","year":"1995","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.bbmt.2018.05.006_bib0025","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/sj.leu.2402307","article-title":"Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantation","volume":"15","author":"Balduini","year":"2001","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.bbmt.2018.05.006_bib0030","first-page":"1035","article-title":"Factors associated with response to platelet transfusion following hematopoietic stem cell transplantation","volume":"17","author":"Klumpp","year":"1996","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.bbmt.2018.05.006_bib0035","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1537-2995.1998.38998409004.x","article-title":"Clinical factors influencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation\u2013a prospective analysis","volume":"38","author":"Ishida","year":"1998","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.bbmt.2018.05.006_bib0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bmt.1702490","article-title":"Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation","volume":"26","author":"Toor","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.bbmt.2018.05.006_bib0045","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1537-2995.2008.01799.x","article-title":"The clinical impact of platelet refractoriness: correlation with bleeding and survival","volume":"48","author":"Kerkhoffs","year":"2008","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.bbmt.2018.05.006_bib0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.transci.2011.06.017","article-title":"The investigation of platelet transfusion refractory in 69 malignant patients undergoing hematopoietic stem cell transplantation","volume":"45","author":"Li","year":"2011","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.bbmt.2018.05.006_bib0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00277-017-3168-6","article-title":"Factors influencing platelet transfusion refractoriness in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"97","author":"Solves","year":"2018","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.bbmt.2018.05.006_bib0060","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1537-2995.1991.31591263191.x","article-title":"Factors influencing 20-hour increments after platelet transfusion","volume":"31","author":"Bishop","year":"1991","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.bbmt.2018.05.006_bib0065","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/trf.13263","article-title":"Pretransplant platelet transfusion refractoriness is not associated with platelet nonengraftment in T-replete hematopoietic progenitor cell transplantation for hematologic malignancies","volume":"56","author":"Scott","year":"2016","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.bbmt.2018.05.006_bib0070","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11427-017-9110-0","article-title":"Platelet transfusion refractoriness after T-cell-replete haploidentical transplantation is associated with inferior clinical outcomes","volume":"61","author":"Fu","year":"2018","journal-title":"Sci China Life Sci"},{"issue":"10","key":"10.1016\/j.bbmt.2018.05.006_bib0075","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa1602074","article-title":"Cord-blood transplantation in patients with minimal residual disease","volume":"375","author":"Milano","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.bbmt.2018.05.006_bib0080","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.bbmt.2015.10.006","article-title":"Comparison of outcomes of 8\/8 and 7\/8 allele-matched unrelated bone marrow transplantation and single-unit cord blood transplantation in adults with acute leukemia","volume":"22","author":"Terakura","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.bbmt.2018.05.006_bib0085","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1182\/blood-2004-03-1001","article-title":"Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies","volume":"104","author":"Takahashi","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bbmt.2018.05.006_bib0090","doi-asserted-by":"crossref","first-page":"E284","DOI":"10.1002\/ajh.24340","article-title":"Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older","volume":"91","author":"Konuma","year":"2016","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.bbmt.2018.05.006_bib0095","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0198-8859(98)00020-2","article-title":"Simultaneous HLA Class I and Class II antibodies screening with flow cytometry","volume":"59","author":"Pei","year":"1998","journal-title":"Hum Immunol"},{"issue":"3","key":"10.1016\/j.bbmt.2018.05.006_bib0100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2008.07189.x","article-title":"Platelet transfusion refractoriness","volume":"142","author":"Hod","year":"2008","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bbmt.2018.05.006_bib0105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.13597","article-title":"Platelet refractoriness\u2013practical approaches and ongoing dilemmas in patient management","volume":"171","author":"Stanworth","year":"2015","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bbmt.2018.05.006_bib0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"23","key":"10.1016\/j.bbmt.2018.05.006_bib0115","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bbmt.2018.05.006_bib0120","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.bbmt.2018.05.006_bib0125","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.3324\/haematol.2014.114504","article-title":"Granulocyte colony-stimulating factor combined regimen in cord blood transplantation for acute myeloid leukemia: a nationwide retrospective analysis in Japan","volume":"99","author":"Konuma","year":"2014","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.bbmt.2018.05.006_bib0130","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3109\/10428194.2014.949261","article-title":"Single-unit cord blood transplant for acute lymphoblastic leukemia and lymphoma using an intensified conditioning regimen of total body irradiation, high-dose cytarabine and cyclophosphamide","volume":"56","author":"Konuma","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.bbmt.2018.05.006_bib0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bbmt.2009.10.022","article-title":"Pre-engraftment syndrome after double-unit cord blood transplantation: a distinct syndrome not associated with acute graft-versus-host disease","volume":"16","author":"Patel","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.bbmt.2018.05.006_bib0140","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.bbmt.2017.07.020","article-title":"Cytokine profiles of pre-engraftment syndrome after single-unit cord blood transplantation for adult patients","volume":"23","author":"Konuma","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bbmt.2018.05.006_bib0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.bmt.1705539","article-title":"Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults","volume":"39","author":"Narimatsu","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bbmt.2018.05.006_bib0150","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/petr.12621","article-title":"Graft-versus-host disease (GVHD) prophylaxis by using methotrexate decreases pre-engraftment syndrome and severe acute GVHD, and accelerates engraftment after cord blood transplantation","volume":"20","author":"Iguchi","year":"2016","journal-title":"Pediatr Transplant"},{"issue":"3","key":"10.1016\/j.bbmt.2018.05.006_bib0155","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/bmt.2016.255","article-title":"Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil","volume":"52","author":"Terakura","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"11\u201312","key":"10.1016\/j.bbmt.2018.05.006_bib0160","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1046\/j.1537-2995.1996.36111297091736.x","article-title":"Influence of antibiotics on posttransfusion platelet increment","volume":"36","author":"B\u00f6ck","year":"1996","journal-title":"Transfusion"},{"issue":"10","key":"10.1016\/j.bbmt.2018.05.006_bib0165","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.05.006_bib0170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.leukres.2017.08.015","article-title":"Platelet transfusion refractoriness in patients with acute myeloid leukemia treated by intensive chemotherapy","volume":"61","author":"Comont","year":"2017","journal-title":"Leuk Res"},{"issue":"4","key":"10.1016\/j.bbmt.2018.05.006_bib0175","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.exphem.2004.01.002","article-title":"Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice","volume":"32","author":"Gluckman","year":"2004","journal-title":"Exp Hematol"},{"issue":"7","key":"10.1016\/j.bbmt.2018.05.006_bib0180","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.bbmt.2017.03.036","article-title":"Cryopreserved CD34+ Cell Dose, but not total nucleated cell dose, influences hematopoietic recovery and extensive chronic graft-versus-host disease after single-unit cord blood transplantation in adult patients","volume":"23","author":"Konuma","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bbmt.2018.05.006_bib0185","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/trf.12817","article-title":"Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation","volume":"55","author":"Christou","year":"2015","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.bbmt.2018.05.006_bib0190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bmt.1705203","article-title":"Prognostic significance of platelet recovery pattern after allogeneic HLA-identical sibling transplantation and its association with severe acute GVHD","volume":"37","author":"Kim","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.bbmt.2018.05.006_bib0195","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/bmt.2010.218","article-title":"Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival","volume":"46","author":"Ram\u00edrez","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bbmt.2018.05.006_bib0200","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/hon.2427","article-title":"Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: association with chronic graft-versus-host disease and survival outcome","volume":"36","author":"Akahoshi","year":"2017","journal-title":"Hematol Oncol"},{"issue":"3","key":"10.1016\/j.bbmt.2018.05.006_bib0205","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3324\/haematol.2012.069559","article-title":"Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients","volume":"98","author":"Labrador","year":"2013","journal-title":"Haematologica"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118302581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118302581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:03:54Z","timestamp":1761059034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879118302581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1083879118302581"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.05.006","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet Transfusion Refractoriness in Single-Unit Cord Blood Transplantation for Adults: Risk Factors and Clinical Outcomes","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}